Nanomedicine and Nanoscale Delivery (Focus Group – NND)
Muhammad Ijaz, BPharm, PhD (he/him/his)
Research Scientist
University Colleg Dublin
Dublin, Dublin, Ireland
GLP-1-RAs are challenged by poor oral bioavailability due to physicochemical factors including high hydrophilicity, high molecular weight ( >4 kDa), and susceptibility to gastrointestinal degradation (1). Recent efforts employing a permeation-enhancer led to approval of oral semaglutide (Rybelsus®), although it has an oral bioavailability of less than 1% (2). Ionic complexes and lipid-based particulate are combined strategies to enhance transmucosal flux. Non-covalently bound lipopeptides exhibit enhanced compatibility with lipid-based drug delivery systems (3). We aim to formulate mucoadhesive buccal films with lipid preconcentrate-entrapped ionic complexes of GLP-1RA